Elon Musk's brain-implant company Neuralink says it has received a green light from the US Food and Drug Administration (FDA) to kickstart its first-in-human clinical study, a critical milestone after earlier struggles to gain approval. ⌘ Read more
Elon Musk's brain-implant company Neuralink says it has received a green light from the US Food and Drug Administration (FDA) to kickstart its first-in-human clinical study, a critical milestone after earlier struggles to gain approval. ⌘ Read more